Acciones F-star Therapeutics, Inc.
Acciones
FSTX
US30315R1077
Biotecnología e investigación médica
Directores | Puesto | Edad | Desde |
---|---|---|---|
Neil Brewis
CEO | Chief Executive Officer | 57 | 20/11/20 |
Lindsey Trickett
IRC | Investor Relations Contact | - | - |
Trish Hurley
LAW | General Counsel | - | - |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Neil Brewis
CEO | Chief Executive Officer | 57 | 20/11/20 |
Varia. 1 de ene. | Capi. | |
---|---|---|
-1,51 % | 105 mil M | |
+3,22 % | 97,5 mil M | |
+1,86 % | 22,19 mil M | |
-16,53 % | 21,33 mil M | |
-8,49 % | 18,68 mil M | |
-42,33 % | 16,6 mil M | |
-20,09 % | 14,52 mil M | |
+5,47 % | 14,09 mil M | |
+28,85 % | 10,99 mil M |